These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16097852)

  • 21. Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
    Akiskal HS; Fuller MA; Hirschfeld RM; Keck PE; Ketter TA; Weisler RH
    CNS Spectr; 2005 Jun; 10(6):suppl 1-11; discuss 12-3; quiz 14-5. PubMed ID: 16041864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Kowatch RA; Emslie GJ; Findling RL; Wilens TE; McCague K; D'Souza J; Wamil A; Lehman RB; Berv D; Linden D
    Am J Psychiatry; 2006 Jul; 163(7):1179-86. PubMed ID: 16816222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():31-4. PubMed ID: 16754411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine extended-release capsules in the treatment of bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():1. PubMed ID: 16754404
    [No Abstract]   [Full Text] [Related]  

  • 27. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamotrigine: a review of its use in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine extended-release capsules: a retrospective review of its use in children and adolescents.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():3-7. PubMed ID: 16754405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF; Khan A; Lane R; Olson WH
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine extended-release capsules in bipolar disorder.
    Weisler RH
    Neuropsychiatr Dis Treat; 2006 Mar; 2(1):3-11. PubMed ID: 19412441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():15-8. PubMed ID: 16754407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():23-6. PubMed ID: 16754409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():27-30. PubMed ID: 16754410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():19-22. PubMed ID: 16754408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.
    Vieta E; Nuamah IF; Lim P; Yuen EC; Palumbo JM; Hough DW; Berwaerts J
    Bipolar Disord; 2010 May; 12(3):230-43. PubMed ID: 20565430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.